XPHELYUM
LIVE

Serial Number

79302219

Owner

XPHELYUM

Attorney

James R Menker

Filing Date

Nov 13, 2020

Add to watchlist:

No watchlists yet
View on USPTO

XPHELYUM Trademark

Serial Number: 79302219 • Registration: 6648819

XPHELYUM is a trademark filed by XPHELYUM on November 13, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

XPHELYUM

16 bis rue d'Odessa,

Entity Type: 99

Trademark Details

Filing Date

November 13, 2020

Registration Date

February 22, 2022

Published for Opposition

December 7, 2021

Goods & Services

Electric apparatus for switching, namely, electric switches; data processing apparatus; intercommunication apparatus, namely, telephones incorporating intercommunication systems; measuring apparatus, namely, analyzers for measuring, testing and analyzing blood and other bodily fluids and temperature sensors used in the medical field to measure temperature of medical solutions, testing and analyzing heartbeat, sensors measuring body functions; monitoring apparatus, other than for medical use, namely, electronic monitors and monitor modules for monitoring electric current and electrical signals; apparatus and instruments for physics, namely, electrodes , sensors collecting physical signals; precision measuring apparatus, namely, lasers for measuring; remote control apparatus, namely, remote control transmitter for radio-controlled devices; chips being integrated circuits; integrated circuits; interfaces for computers; microprocessors; Processors being central processing units, central processing units for processing information, data, sound, speech or images; telecommunications transmitters; smart rings; telecommunication apparatus in the form of jewelry, namely, smart rings; Wearable computers in the nature of smart glasses and smart watches

Biological preparations for medical use for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; Biological preparations for medical use for the treatment of inflammatory conditions, autoimmune diseases, inflammatory bowel disease, arthritis, migraines, metabolic disorders, obesity, diabetes, paralysis, sensory disorders and impairments, hypertension, cancer, cardiac rhythm management, sleep apnea, Parkinson disease, Alzheimer's disease, dystonia, neurodegenerative diseases, obsessive compulsive disorder, depressive disorders, arrhythmias, epilepsy, incontinence and chronic pain; biological preparations for veterinary use for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; chemical preparations for medical use for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; chemical preparations for medical use for the treatment of inflammatory conditions, autoimmune diseases, inflammatory bowel disease, arthritis, migraines, metabolic disorders, obesity, diabetes, paralysis, sensory disorders and impairments, hypertension, cancer, cardiac rhythm management, sleep apnea, Parkinson disease, Alzheimer's disease, dystonia, neurodegenerative diseases, obsessive compulsive disorder, depressive disorders, arrhythmias, epilepsy, incontinence and chronic pain; biological preparations for veterinary use for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; chemical preparations for pharmaceutical use, namely for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; chemical preparations for veterinary use, namely, for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; chemical reagents for medical or veterinary use; chemical-pharmaceutical preparations for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; drugs for medical use for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; drugs for medical use for the treatment of inflammatory conditions, autoimmune diseases, inflammatory bowel disease, arthritis, migraines, metabolic disorders, obesity, diabetes, paralysis, sensory disorders and impairments, hypertension, cancer, cardiac rhythm management, sleep apnea, Parkinson disease, Alzheimer's disease, dystonia, neurodegenerative diseases, obsessive compulsive disorder, depressive disorders, arrhythmias, epilepsy, incontinence and chronic pain; medicines for human medicine for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; pharmaceutical preparations for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; pharmaceutical products for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; pharmaceutical preparations and pharmaceutical products for the treatment of inflammatory conditions, autoimmune diseases, inflammatory bowel disease, arthritis, migraines, metabolic disorders, obesity, diabetes, paralysis, sensory disorders and impairments, hypertension, cancer, cardiac rhythm management, sleep apnea, Parkinson disease, Alzheimer's disease, dystonia, neurodegenerative diseases, obsessive compulsive disorder, depressive disorders, arrhythmias, epilepsy, incontinence and chronic pain

Health care services; telemedicine services; therapy services, namely, physical therapy and mental health therapy services

Medical apparatus and instruments for stimulating the nervous system; veterinary apparatus and instruments for stimulating the nervous system

Industrial research in biology; industrial research in chemistry; conducting clinical trials for others; medical research; scientific research; industrial research relating to technology; industrial research in the field of physics; industrial research in the field of telecommunication technology

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 16, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 27, 2022 FICS
FINAL DISPOSITION PROCESSED
Jul 27, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 22, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 22, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 7, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 7, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Dec 6, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 17, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 17, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 2, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 14, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 14, 2021 TROA
REFUSAL PROCESSED BY IB
May 30, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 8, 2021 RFCS
REFUSAL PROCESSED BY MPU
May 5, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 5, 2021 RFCR
NON-FINAL ACTION WRITTEN
May 4, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 24, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 19, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 14, 2021 REPR